OCT-1 overexpression is associated with poor prognosis in patients with well-differentiated gastric cancer
- 25 February 2014
- journal article
- Published by Springer Nature in Tumor Biology
- Vol. 35 (6) , 5501-5509
Abstract
Octamer transcription factor-1 (OCT-1) is a well-known transcription factor that is reportedly overexpressed in intestinal metaplasia and gastric carcinoma in the intestine. In this study, we investigated OCT-1 overexpression as a prognostic factor for gastric cancer. The association between OCT-1 overexpression (detected using immunohistochemistry) and clinicopathological features including survival was evaluated. In vitro gain-of-function approaches were utilized to assess the function of OCT-1 in malignancy. Analysis of OCT-1 expression in patients with gastric cancer with well-differentiated carcinoma as per the World Health Organization classification showed that OCT-1 overexpression was correlated with advanced tumor invasion (58.8 % of patients with advanced tumor invasion vs. 21.2 % of patients with early tumor invasion; p < 0.01), lymph node metastasis (63.9 % of patients with metastasis vs. 24.1 % of those without; p = 0.015), and cancer recurrence (83.3 % of patients with recurrence vs. 25.4 % of those without; p < 0.01), as well as a lower survival rate (62.8 vs. 87.9 Mo; p < 0.01). However, there were no significant differences in the levels of OCT-1 expression in gastric cancer patients with other carcinoma types (p > 0.05). Furthermore, we found that the proliferation rate of OCT-1-overexpressing MKN-45 cells was higher than that of the control cells. OCT-1 overexpression may be a marker for poor prognosis in patients with well-differentiated gastric adenocarcinoma.Keywords
This publication has 22 references indexed in Scilit:
- POU Homeodomain Protein Oct-1 Functions as a Sensor for Cyclic AMPJournal of Biological Chemistry, 2009
- Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicityNature Cell Biology, 2009
- Oct-1 induces pituitary tumor transforming gene expression in endocrine tumorsEndocrine-Related Cancer, 2008
- Oncomine 3.0: Genes, Pathways, and Networks in a Collection of 18,000 Cancer Gene Expression ProfilesNeoplasia, 2007
- Hypoxia-inducible factor-1α expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomasBritish Journal of Cancer, 2006
- Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancerWorld Journal of Gastroenterology, 2006
- The Octamer Binding Transcription Factor Oct-1 Is a Stress SensorCancer Research, 2005
- A proposal for diagnostically meaningful criteria to classify increased epidermal growth factor receptor and c-erbB-2 gene copy numbers in gastric carcinoma, based on correlation of fluorescence in situ hybridization and immunohistochemical measurementsVirchows Archiv, 2004
- CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: Prognostic implicationsInternational Journal of Oncology, 2002
- Gastric cancer in KoreaGastric Cancer, 2002